Cyril Gay | Senior National Program Leader
A.R.S. National Programs

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Dr. Gay obtained a BSc in Chemistry and a Doctor of Veterinary Medicine from Auburn University, and a Ph.D. in Microbiology from The George Washington University.  Dr. Gay has worked in the animal health research field for the last 25 years holding several positions of increasing responsibility in the federal government and the pharmaceutical industry.  As Chief, Biotechnology Section, Center for Veterinary Biologics (CVB), United States Department of Agriculture (USDA), Dr. Gay developed the procedures for licensing molecular vaccines that led to the first license for a live recombinant vectored vaccine.  In the pharmaceutical industry (SmithKline Beecham Animal Health and Pfizer Animal Health) Dr. Gay led several cross-functional teams that successfully developed and licensed veterinary vaccines for companion animals and livestock.

As Director, Global Product Development, Pfizer Inc., Dr. Gay developed strategic and tactical plans that interfaced R&D, clinical development, manufacturing, marketing, and product life-cycle management.  Dr. Gay joined Agricultural Research Service (ARS), USDA, in 2002.  Dr. Gay currently holds the position of Senior National Program Leader and provides program direction and national coordination for the Department’s intramural animal health research program, with focus on eight research laboratories located in Ames, Iowa, East Lansing, Michigan, Clay Center, Nebraska, Athens, Georgia, Orient Point, New York, Beltsville, Maryland, Pullman, Washington, and Manhattan, Kansas.  Dr. Gay was the 2010 recipient of the USDA Secretary’s Honors Award for interagency response to the pandemic H1N1 influenza outbreak; the ARS Special Administrator’s Award for outstanding and rapid research support for pandemic H1N1; and the USDA Secretary’s Honor Award for Heroism and Emergency Response for contributions as a team member to the ARS/APHIS response to the 2013 Chinese H7N9 avian influenza outbreak.


Pre-congress Workshops, April 6 @ 10:00


Harmonizing national and international priorities – what is the role of public health and government in implementation AMR efforts? Collaborative strategies from industry to halting the AMR crisis – do we have a consistent message? 10:00 Workshop leader opening remarks10:10 Vaccines as Another Strategy to Reduce Antibiotic Resistance in Healthcare Settings10:40 Gaps in veterinary vaccines to address AMR11:10 Why do we think this is possible? Update on vaccine technology that is enabling better vaccinesPipeline updates from biotech and industry – alternatives from antibiotics11:40 TB vaccines12:10 Bacterial Vaccine Polypeptides12:25 Vaccine efforts in Acinetobacter baumannii12:40 Update on the development of a Klebsiella and Pseudomonas vaccine

Pre-congress Workshops, April 6 @ 2:00


PM: SHORTENING THE INNOVATION PIPELINE FOR ANIMAL HEALTH PRODUCTSWorkshop Collaboration with STAR-IDAZ IRCWorkshop Leader: Alex Morrow, Chair of The International Research Consortium, STAR-IDAZ IRC Presentation topics include:Introduction to the research road maps: Vaccines, therapeutics, diagnostics
  • What are the opportunities for collaboration and co-funding with other agencies around the world which would allow sharing of expertise and resources internationally?
  • What do we as research funders and programme managers need to do, to ensure that the research community and industry work better together to shorten the innovation pipeline?
  • How can we get the research institutes engaging with the animal health companies at an earlier stage?
  • How can we guarantee that the funding activities of public funders are addressing the underpinning needs of the more strategic/applied end of the innovation pipeline?

Plenary, April 7 @ 14:30

Chair's opening remarks

Day 2, April 8 @ 09:00

Chair’s opening remarks

Day 3, April 9 @ 09:00

Chair's opening remarks

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates